Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals
2 other identifiers
interventional
10
1 country
1
Brief Summary
Accumulating evidence from epidemiological and human intervention studies indicates that the cardiovascular health benefits of diets rich in fruits and vegetables are (in part) related to their (poly)phenol content. Raspberries are rich in phenolic and polyphenolic compounds, in particular procyanidins, ellagitannins and anthocyanins, but also phenolic acids. At present, a small number of randomized controlled trials investigating the effects of berry (poly)phenols on validated surrogate markers of cardiovascular disease risk have shown promising results. However, to date, very few human studies have specifically investigated the effects of raspberry (poly)phenols on cardiovascular function in healthy subjects. Moreover, ellagitannin-derived metabolites are believed to persist for a long period of time in the blood and urine. Therefore, the investigators will investigate the presence of plasma and urinary raspberry-derived metabolites 24h post-consumption. To the investigators knowledge, the effects of red raspberry consumption on vascular function in humans have not been investigated before. This information is necessary for the planning of long-term studies aiming to assess the potential beneficial effects of raspberries,. Therefore, this study aims to investigate the potential role of red raspberry (poly)phenols in the modulation of vascular function by monitoring changes in vascular function together with the major (poly)phenol derivatives/metabolites in plasma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 9, 2016
CompletedFirst Posted
Study publicly available on registry
April 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 20, 2016
October 1, 2016
6 months
March 9, 2016
October 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline to 2 hour and 24 hour in Endothelial function
measured by flow mediated dilation (FMD) on baseline at 2 and 24 hour postconsumption
Baseline, 2 hour and 24 hour
Secondary Outcomes (4)
Change from baseline to 2 hour and 24 hour in Pulse wave velocity
Baseline, 2 hour and 24 hour
Change from baseline to 2 hour and 24 hour in Central blood pressure
Baseline, 2 hour and 24 hour
Peripheral blood pressure
Baseline, 2 h and 24 h
Change from baseline to 2 hour and 24 hour in Heart rate
Baseline, 2 hour and 24 hour
Other Outcomes (2)
Change from baseline to 2 hour and 24 hour in Polyphenol metabolites in blood plasma
Baseline, 2 hour and 24 hour
Change from baseline to 2 hour and 24 hour in Polyphenol metabolites in urine
Baseline, 2 hour and 24 hour
Study Arms (3)
400 g frozen raspberries
ACTIVE COMPARATORRed raspberry beverage Acute intake of 600 mL (1x daily)
200 g frozen raspberries
ACTIVE COMPARATORRed raspberry beverage Acute intake of 600 mL (1x daily)
Placebo control
PLACEBO COMPARATORRaspberry deprived supplement Acute intake of 600 mL (1x daily)
Interventions
1x daily intake of 600 mL red raspberry beverage
1x daily intake of 600 mL red raspberry beverage
Eligibility Criteria
You may qualify if:
- healthy male subjects (no clinical signs or symptoms of cardiovascular disease)
You may not qualify if:
- Cardiovascular disease
- acute inflammation
- cardiac arrhythmia
- renal failure
- heart failure (NYHA II-IV)
- diabetes mellitus
- C - reactive protein \> 05 mg/dL
- malignant disease
- raspberry allergy/intolerance
- hypotension (≤100 / 60 mm Hg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf
Düsseldorf, 40225, Germany
Related Publications (1)
Istas G, Feliciano RP, Weber T, Garcia-Villalba R, Tomas-Barberan F, Heiss C, Rodriguez-Mateos A. Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: A double-blind randomized controlled trial. Arch Biochem Biophys. 2018 Aug 1;651:43-51. doi: 10.1016/j.abb.2018.05.016. Epub 2018 May 24.
PMID: 29802820DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Rodriguez-Mateos, PhD
Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf
- PRINCIPAL INVESTIGATOR
Christian Heiss, MD
Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital Duesseldorf
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2016
First Posted
April 12, 2016
Study Start
March 1, 2016
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
October 20, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share